Tachatra Ungsudechachai1,2, Sittisak Honsawek3, Jiraphun Jittikoon1, Wanvisa Udomsinprasert1. 1. Department of Biochemistry, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand. 2. Pharmacology and Biomolecular Science Graduate Program, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand. 3. Department of Biochemistry, Osteoarthritis and Musculoskeleton Research Unit, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Abstract
OBJECTIVES: This study aimed to determine possible associations between transcriptional and translational levels of clusterin (CLU) in the systemic and local joint environments with the severity of knee osteoarthritis (OA) and to investigate CLU mRNA expression in knee OA fibroblast-like synoviocytes (FLSs) stimulated with tumor necrosis factor-α. DESIGN: Circulating and synovial fluid CLU levels in 259 knee OA patients were quantified using an enzyme-linked immunosorbent assay. Relative CLU mRNA expression in 50 knee OA synovial tissues and 4 knee OA FLSs was determined using real-time polymerase chain reaction. RESULTS: Plasma CLU levels of knee OA patients were significantly higher than paired synovial fluid samples. Compared with early-stage knee OA patients, those with advanced-stage OA had considerably increased plasma and synovial fluid CLU levels. There were significant positive associations of plasma and synovial fluid CLU levels with radiographic severity of knee OA. Plasma CLU levels were directly correlated with its synovial fluid levels and high-sensitivity C-reactive protein levels in the patients. Receiver-operating characteristic curve analysis unveiled the potential utility of plasma CLU as a novel biomarker for knee OA severity (AUC = 0.80), with a sensitivity of 71.4% and a specificity of 73.3%. Marked upregulation of CLU mRNA expression was observed in both the inflamed synovial tissues and FLSs of knee OA. CONCLUSION: Increased CLU mRNA and protein levels in the systemic and local joint environments of knee OA might reflect knee OA severity, especially systemic and synovial inflammation.
OBJECTIVES: This study aimed to determine possible associations between transcriptional and translational levels of clusterin (CLU) in the systemic and local joint environments with the severity of knee osteoarthritis (OA) and to investigate CLU mRNA expression in knee OA fibroblast-like synoviocytes (FLSs) stimulated with tumor necrosis factor-α. DESIGN: Circulating and synovial fluid CLU levels in 259 knee OA patients were quantified using an enzyme-linked immunosorbent assay. Relative CLU mRNA expression in 50 knee OA synovial tissues and 4 knee OA FLSs was determined using real-time polymerase chain reaction. RESULTS: Plasma CLU levels of knee OA patients were significantly higher than paired synovial fluid samples. Compared with early-stage knee OA patients, those with advanced-stage OA had considerably increased plasma and synovial fluid CLU levels. There were significant positive associations of plasma and synovial fluid CLU levels with radiographic severity of knee OA. Plasma CLU levels were directly correlated with its synovial fluid levels and high-sensitivity C-reactive protein levels in the patients. Receiver-operating characteristic curve analysis unveiled the potential utility of plasma CLU as a novel biomarker for knee OA severity (AUC = 0.80), with a sensitivity of 71.4% and a specificity of 73.3%. Marked upregulation of CLU mRNA expression was observed in both the inflamed synovial tissues and FLSs of knee OA. CONCLUSION: Increased CLU mRNA and protein levels in the systemic and local joint environments of knee OA might reflect knee OA severity, especially systemic and synovial inflammation.
Authors: M Chemel; B Le Goff; R Brion; C Cozic; M Berreur; J Amiaud; G Bougras; S Touchais; F Blanchard; M F Heymann; J M Berthelot; F Verrecchia; D Heymann Journal: Ann Rheum Dis Date: 2011-10-28 Impact factor: 19.103
Authors: Seung-Jae Kim; Zhenlong Chen; Abdul B Essani; Hatem A Elshabrawy; Michael V Volin; Giamila Fantuzzi; Iain B McInnes; Joshua F Baker; Patricia Finn; George Kondos; Suncica Volkov; William Swedler; Shiva Arami; Nadera Sweiss; Shiva Shahrara Journal: Ann Rheum Dis Date: 2016-10-18 Impact factor: 19.103
Authors: I Hardardóttir; S T Kunitake; A H Moser; W T Doerrler; J H Rapp; C Grünfeld; K R Feingold Journal: J Clin Invest Date: 1994-09 Impact factor: 14.808
Authors: Ioannis P Trougakos; Magda Lourda; Marianna H Antonelou; Dimitris Kletsas; Vassilis G Gorgoulis; Issidora S Papassideri; Yonglong Zou; Lukas H Margaritis; David A Boothman; Efstathios S Gonos Journal: Clin Cancer Res Date: 2009-01-01 Impact factor: 12.531
Authors: Stefano Alivernini; Barbara Tolusso; Maria Rita Gigante; Luca Petricca; Laura Bui; Anna Laura Fedele; Clara Di Mario; Roberta Benvenuto; Francesco Federico; Gianfranco Ferraccioli; Elisa Gremese Journal: Sci Rep Date: 2019-07-18 Impact factor: 4.379